PHARMAC have announced CGM funding for people with Type 1 diabetes from 1 October 2024. More detail to come.Additional information on Diabetes New Zealand website and the Pharmac Websites
You have nothing in your cart.
If you know the product code enter it here
If you know the product code enter it into the search field
PE/Dazzle™ 594 anti-mouse CD150 (SLAM), 100 μg
PE/Dazzle™ 594 anti-mouse CD150 (SLAM), 25 μg
PE/Dazzle™ 594 anti-mouse CD152, 100 μg
PE/Dazzle™ 594 anti-mouse CD152, 25 μg
PE/Dazzle™ 594 anti-mouse CD155 (PVR), 100 μg
PE/Dazzle™ 594 anti-mouse CD155 (PVR), 25 μg
PE/Dazzle™ 594 anti-mouse CD16.2 (FcγRIV), 100 μg
PE/Dazzle™ 594 anti-mouse CD172a (SIRPα), 100 μg
PE/Dazzle™ 594 anti-mouse CD172a (SIRPα), 25 μg
PE/Dazzle™ 594 anti-mouse CD183 (CXCR3), 100 μg
PE/Dazzle™ 594 anti-mouse CD183 (CXCR3), 25 μg
PE/Dazzle™ 594 anti-mouse CD184 (CXCR4), 100 μg
PE/Dazzle™ 594 anti-mouse CD184 (CXCR4), 25 μg
PE/Dazzle™ 594 anti-mouse CD185 (CXCR5), 100 μg
PE/Dazzle™ 594 anti-mouse CD185 (CXCR5), 25 μg
PE/Dazzle™ 594 anti-mouse CD19, 100 μg